Apixaban shows more efficacy and safety than rivaroxaban in patients with atrial fibrillation and valvular heart disease
Among patients diagnosed with atrial fibrillation (AF) and valvular heart disease (VHD), those treated with apixaban have achieved a lower rate of ischemic stroke or systemic embolism and… read more.